Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Mild asthma
- The usual starting dose is 100 micrograms twice a day
Flixotide Accuhaler packs - now all under £5.00
Providing an affordable, low carbon option for appropriate patients with asthma who need an inhaled corticosteroid
Please consult product SmPCs for specific indications and dosing regimens
| Brand | BTS/SIGN Adult Dose2 | List price | 30 day cost |
|---|---|---|---|
| Low dose2 | |||
| Flixotide 100mcg Accuhaler 60 dose | 1 puff BD | £4.02 | £4.02 |
| Pulmicort 100mcg Turbohaler 200 dose | 2 puffs BD | £14.25 | £8.55 |
| Pulmicort 200mcg Turbohaler 100 dose | 1 puff BD | £14.25 | £8.55 |
| Clenil Modulite 100mcg 200 dose | 2 puffs BD | £7.42 | £4.45 |
| Qvar MDI 50mcg 200 dose | 2 puffs BD | £7.87 | £4.72 |
| Medium dose2 | |||
| Flixotide 250mcg Accuhaler 60 dose | 1 puff BD | £4.23 | £4.23 |
| Pulmicort 200mcg Turbohaler 100 dose | 2 puffs BD | £14.25 | £17.10 |
| Pulmicort 400mcg Turbohaler 50 dose | 1 puff BD | £14.25 | £17.10 |
| Clenil Modulite 200mcg 200 dose | 2 puffs BD | £16.17 | £9.70 |
| Qvar MDI 100mcg 200 dose | 2 puffs BD | £17.21 | £10.33 |
| High dose2 | |||
| Flixotide 500mcg Accuhaler | 1 puff BD | £4.73 | £4.73 |
| Pulmicort 400mcg Turbohaler | 2 puffs BD | £14.25 | £34.20 |
| Clenil Modulite 250mcg | 2 puffs BD | £16.29 | £9.77 |
| Clenil Modulite 250mcg | 4 puffs BD | £16.29 | £19.55 |
| Qvar MDI 100mcg 200 dose | 4 puffs BD | £17.21 | £20.65 |
In order to calculate which brands are commonly prescribed, where a brand has more than one strength pack, the pack volumes have been added together to give total brand volume
Consult SmPC's for specific indications and dosing regimens.
Not all ICSs are the same molecule. Flixotide is fluticasone propionate, Pulmicort is budesonide, Qvar and Clenil are beclomethasone dipropionate
The price of three Flixotide Accuhaler packs have been significantly reduced to enable low cost, low carbon ICS prescribing
Flixotide Accuhaler Indication3
Flixotide Accuhaler offers preventative treatment for asthma.
For Adults: Prophylactic management in mild asthma for patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis; prophylactic management in moderate asthma for patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone; prophylactic management in severe asthma for patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.
For children: Any child who requires prophylactic medication for asthma, including patients not controlled on currently available prophylactic medication.
Dosing4
Moderate to severe asthma
- The usual starting dose is 250 to 500 micrograms twice a day
- The most taken should be 1000 micrograms twice a day
Children (4 to 16 years of age):
- The usual starting dose is 50 micrograms twice a day
- The most taken should be 200 micrograms twice a day
- Flixotide Accuhaler 250 micrograms and Flixotide Accuhaler 500 micrograms are not recommended for children 16 years and under
Be proactive, control asthma: resources to help you to support patients
Choose Accuhaler, reduce carbon
Prescribing Information Links
Flixotide Prescribing Information (PDF)
References
- IQVIA prescribed data volume MAT April 2022
- BTS/SIGN Asthma Guideline 2019. Table 12
- Flixotide Accuhaler SPC
- Flixotide Accuhaler Patient Information Leaflet (PIL)
- Nathan RA et al. J Allergy Clin Immunol 2004;113:59-65
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
© 2021 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
Third party trade marks are the property of their respective owners
March 2023 | PM-GB-FLP-WCNT-220002 (V2.0)
